Featuring Celeste Alvarez, PhD, Shayla Love, Raad Seraj, Savva Kerdemelidis, LLM, BSc, Jeffrey Zuber, Graham Pechenik, Esq.
The patent gold rush shows no signs of slowing. But are patents the best instrument to promote innovation, enhance the quality of available treatments, and improve access to psychedelic medicine? Will this undermine advancement in the field, or could alternative incentive models be the best way to ensure investment and ultimate commercialization?
We’ll discuss different strategies and alternative incentive models for psychedelic innovation (including regulatory exclusivity and prizes/pay-for-success), and analyze each from different perspectives across the space
4:15 pm
Main Stage
Nov 4
Featuring Celeste Alvarez, PhD, Shayla Love, Raad Seraj, Savva Kerdemelidis, LLM, BSc, Jeffrey Zuber, Graham Pechenik, Esq.
The patent gold rush shows no signs of slowing. But are patents the best instrument to promote innovation, enhance the quality of available treatments, and improve access to psychedelic medicine? Will this undermine advancement in the field, or could alternative incentive models be the best way to ensure investment and ultimate commercialization?
We’ll discuss different strategies and alternative incentive models for psychedelic innovation (including regulatory exclusivity and prizes/pay-for-success), and analyze each from different perspectives across the space